Evaluation of Serum Serotonin as a Biomarker for Myocardial Infarction and Ischemia/Reperfusion Injury
Background: Activated platelets release serotonin during acute myocardial infarction (AMI), aggravating myocardial damage and ischemia/reperfusion (I/R) injury.However, serum serotonin and its potential role as a biomarker for myocardial infarction and I/R injury have not been studied so far.Methods: In this investigator-initiated pilot study, we e